About this trial
The goal of this NIH-sponsored study is to characterize three biomarkers derived from 129Xe gas exchange MRI and to understand how they change in response to interventions.
Eligibility criteria
Qualifiers
Outpatients of either gender, age > 18
Willing and able to give informed consent and adhere to visit/protocol (Consent must be given before any study procedures are performed.)
Subject has no diagnosed pulmonary conditions
Subject has not smoked in the previous 5 years
Disqualifiers
MRI is contraindicated based on responses to MRI screening questionnaire
Subject is pregnant or lactating
Resting O2 saturation <90% with maximum supplemental O2 delivered by nasal canula
Respiratory illness of a bacterial or viral etiology within 30 days of MRI
Trial design
Treatments tested in this trial
- Hyperpolarized Xe129
- Oxygen Administration
Treatment groups
Sponsors and collaborators
Bastiaan Driehuys
Lead sponsor
Duke University
Sponsor institution
National Institutes of Health (NIH)
Collaborator